As the nation’s mental health crisis deepens, psychedelics and other unconventional therapies are being used to treat debilitating depression and other mental disorders.
One of those drugs is the sedative Ketamine, also known as Special K, a once popular club drug. Now it’s being used for therapy that some call life-saving, while others are wary.
Many of the treatments are not approved by the FDA.
We’ll look at the increased use of Ketamine and its potential benefits and dangers.
Guests:
- Chris Hamby, investigative reporter at The New York Times
- Dr. Gerard Sanacora, Director of the Yale Depression Research Program
- Adam Levin, psychiatry resident at the Center for Psychedelic Drug Research and Education at The Ohio State University
If you have a disability and would like a transcript or other accommodation you can request an alternative format.